It was a pleasure to welcome the Private Sector Council of the ATOM Coalition.

Building on shared achievements, we explored new opportunities and next steps. Together, we're advancing access to vital oncology medicines, ensuring every patient receives the care they need.

Exciting news! The UICC-led ATOM Coalition signed a Memorandum of Understanding with the Ministry of Health to improve access to essential cancer medicines.

uicc.org/announcements/…

A great achievement! The The Max Foundation and BeiGene, two partners of the ATOM Coalition are making strides to provide vital support to those who need it most. Union for International #CancerControl

The ATOM Coalition and IDA Foundation collaborate to improve access to oncology medicines in LLMICs.

Discover how this partnership is making strides towards better cancer control worldwide.

uicc.org/announcements/…

Nearly 10 million people die from cancer every year.

At #WEF24 Dr Cary Adams, CEO of UICC, discussed how to increase cancer care access in LMICs with co-hosts @IAEAorg and The Lancet.

Watch session👉 bit.ly/47vARTG

#CancerCare4All #CloseTheCareGap

Excellent talk by gilberto lopes on access to cancer medicines - we still have along way to go ! ATOM Coalition RoySocMed ecancer The Lancet Oncology Susannah Stanway UKI Global Cancer Network

'No one plans or intends for access to be as inequitable as it is. If we come together in non-traditional ways, we can break through previously intractable barriers to create sustainable access models for patients.'

Recommended read from our partners BeiGene The Max Foundation

By speaking about the Atom Coalition at the AORTIC International Conference on Cancer in Dakar, we hope to forge new partnerships that will help reduce the equity gaps in access to cancer medicines. Dan Milner, MD. MSc(Epi), MBA

Patients in low-income countries often do not have access to life-saving cancer medicines. Initiatives like World Health Organization (WHO), GBCI and ATOM Coalition bridge the global healthcare divide.

Read the blog by Yehoda Martei MD, MSCE, from the University of Pennsylvania.

uicc.org/blog/breast-ca…

Our industry is working to improve health outcomes for people living with cancer 🌎through collaborations & partnerships.

The ATOM Coalition is an example of a global initiative working to ensure that cancer patients receive care & treatment

➡️ifpma.info/468oyga

MPP ED Charles Gore was interviewed🎙️during #WCLS2023
✅shared insights on the 1⃣st ever voluntary licence for a #cancer medicine btw Novartis & MPP, under the auspices of the Union for International #CancerControl-led ATOM Coalition
✅ #PublicHealth -oriented voluntary licensing can increase access to…

In February, we published a framework for assessing #generic & #biosimilar medicine manufacturers on their #access2meds efforts. Shalini Jayasekar Zurn, Senior Advocacy Manager at Union for International #CancerControl, reflects on the value of the framework for achieving equitable access. ⤵️ youtu.be/yq4OXkHKoF0

For the first time, Access to Medicine Foundation's new report focuses on how #generic & #biosimilar manufacturers are making strides in low and middle-income countries—and what more can be done to strengthen #access2meds .

⬇️

Our recent report on the importance of the #generic industry in #access2meds is making waves in the media and sparking conversation with its valuable insights. Read Chris Kay featuring our work in Bloomberg here: bloomberg.com/news/articles/……
Julia Kollewe Jenny Lei Ravelo

#Cancer isn't a one-organisation problem; it's a global challenge that needs all of us.

Thanks to ATOM Coalition partners like IFPMA, we're working to pioneer access solutions for cancer medicines that benefit the good of everyone, everywhere. 🌍

#AlwaysInnovating

💊 The addition of 2 #cancer meds to the World Health Organization (WHO)’s #EML is positive progress, but with <50% of these lifesaving drugs reaching patients in LMICs, more work is needed.

Union for International #CancerControl and the #ATOMCoalition , in collaboration with partners like Amgen 🧪🔬🧬, is committed to closing this access gap.

Fewer than 50% of “essential medicines” are available in low- and middle-income nations, per the World Health Organization (WHO), leading to more #cancer deaths in those areas. The ATOM Coalition is working toward better access to #healthcare worldwide, says gilberto lopes. Learn more: loom.ly/ACuF7TY

Congratulations to #ATOMCoalition partner, IDA Foundation on leading the development of a new pooled procurement marketplace that will transform access to NCD medicines in LMICs.

Excited to be part of ensuring essential #cancer medicines reach those who need them!

#Breaking | 4⃣ generic manufacturers✍️🏽sign sublicence agreements with MPP to produce generic versions of Novartis’ #nilotinib for the treatment of chronic myeloid #leukaemia .

Access our #PressRelease 👉🏽 bit.ly/468Rk0F

#HealthForAll #Access2Meds #PublicHealth #cancer

💊 An insightful conversation on the complexities and potential pathways to achieving equitable #access to #cancer medicines.

Add UICC's latest podcast episode to your playlist ⬇️

World Health Organization (WHO) Charles Gore MedicinesPatentPool